Inventor
LIU TONGYAO
US16 patents
⚠️ This page may combine multiple inventors who share the name “LIU TONGYAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOVERATIV THERAPEUTICS INC
15 patentsUS10138291B2Nov 27, 2018
Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof
BIOVERATIV THERAPEUTICS INC30 citations92
US11192936B2Dec 7, 2021
Factor VIII chimeric proteins and uses thereof
BIOVERATIV THERAPEUTICS INC10 citations84
US10548953B2Feb 4, 2020
Factor VIII-XTEN fusions and uses thereof
BIOVERATIV THERAPEUTICS INC6 citations83
US11286528B2Mar 29, 2022
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
BIOVERATIV THERAPEUTICS INC4 citations82
US11091534B2Aug 17, 2021
Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof
BIOVERATIV THERAPEUTICS INC8 citations82
US10221455B2Mar 5, 2019
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
BIOVERATIV THERAPEUTICS INC5 citations82
US11008561B2May 18, 2021
Optimized factor IX gene
BIOVERATIV THERAPEUTICS INC4 citations73
US11753461B2Sep 12, 2023
Optimized factor VIII genes
BIOVERATIV THERAPEUTICS INC3 citations72
US11370827B2Jun 28, 2022
Chimeric factor VIII polypeptides and uses thereof
BIOVERATIV THERAPEUTICS INC5 citations72
US10745680B2Aug 18, 2020
Factor IX fusion proteins and methods of making and using same
BIOVERATIV THERAPEUTICS INC6 citations69
US12275970B2Apr 15, 2025
Optimized factor IX gene
BIOVERATIV THERAPEUTICS INC1 citations64
US12371747B2Jul 29, 2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
BIOVERATIV THERAPEUTICS INC0 citations60
US12173307B2Dec 24, 2024
Methods for the purification of viral vectors
BIOVERATIV THERAPEUTICS INC0 citations55
US12168776B2Dec 17, 2024
Nucleic acid molecules and uses thereof
BIOVERATIV THERAPEUTICS INC1 citations53
US12364774B2Jul 22, 2025
Nucleic acid molecules and uses thereof for non-viral gene therapy
BIOVERATIV THERAPEUTICS INC0 citations52